Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context. Braz. J. Pharm. Sci. 2012;48(2):227-236. doi:10.1590/S1984-82502012000200006